Marketing-authorisation holder · United Kingdom
Bristol-Myers Squibb Pharma Eeig
126 medicines in 3 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United Kingdom
126 medicines in 3 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 126
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABECMADispersione per infusione | Idecabtagene vicleucel | Italy | Authorised | |
| Abecma | Idecabtagene vicleucel | EU (EMA) | Authorised | 2021 |
| Abecma 260-500 x 10^6 cellen dispersie voor infusieDispersie voor infusie | Idecabtagene vicleucel | Netherlands | Authorised | 2021 |
| Abraxane | Paclitaxel | EU (EMA) | Authorised | 2008 |
| ABRAXANEPolvere per sospensione iniettabile | Paclitaxel | Italy | Authorised | |
| Abraxane 5 mg/ml, lyofilisaat voor suspensie voor injectie | Paclitaxel | Netherlands | Authorised | 2008 |
| AUGTYROCapsula rigida | Repotrectinib | Italy | Authorised | |
| Augtyro | Repotrectinib | EU (EMA) | Authorised | 2025 |
| AUGTYRO 160 mg harde capsulesCapsule, hard | Repotrectinib | Netherlands | Authorised | 2025 |
| AUGTYRO 40 mg harde capsulesCapsule, hard | Repotrectinib | Netherlands | Authorised | 2025 |
| Baraclude | Entecavir | EU (EMA) | Authorised | 2006 |
| BARACLUDECompressa rivestita con film | Entecavir | Italy | Authorised | |
| Baraclude 0,05 mg/ml, drankDrank | Entecavir | Netherlands | Authorised | 2006 |
| Baraclude 0,5 mg, filmomhulde tablettenFilmomhulde tablet | Entecavir | Netherlands | Authorised | 2006 |
| Baraclude 1 mg, filmomhulde tablettenFilmomhulde tablet | Entecavir | Netherlands | Authorised | 2006 |
| BREYANZIDispersione per infusione | Lisocabtagene maraleucel | Italy | Authorised | |
| Breyanzi | Lisocabtagene maraleucel | EU (EMA) | Authorised | 2022 |
| CAMZYOSCapsula rigida | Mavacamten | Italy | Authorised | |
| Camzyos | Mavacamten | EU (EMA) | Authorised | 2023 |
| CAMZYOS 10 mg harde capsulesCapsule, hard | Mavacamten | Netherlands | Authorised | 2023 |
| CAMZYOS 15 mg harde capsulesCapsule, hard | Mavacamten | Netherlands | Authorised | 2023 |
| CAMZYOS 2,5 mg harde capsulesCapsule, hard | Mavacamten | Netherlands | Authorised | 2023 |
| CAMZYOS 5 mg harde capsulesCapsule, hard | Mavacamten | Netherlands | Authorised | 2023 |
| Daklinza 30 mg filmomhulde tablettenFilmomhulde tablet | Daclatasvir | Netherlands | Authorised | 2014 |
| Daklinza 60 mg filmomhulde tablettenFilmomhulde tablet | Daclatasvir | Netherlands | Authorised | 2014 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 67 | 67 | 0 | CompaniesAll medicines |
| European Union (EMA) | 34 | 25 | 9 | CompaniesAll medicines |
| Italy | 25 | 25 | 0 | CompaniesAll medicines |
Also in the registers of Romania, Spain, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.